Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. ( Nasdaq: DECA ) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion - Denali Capital ( NASDAQ:DECA ) , Scilex Holding ( NASDAQ:SCLX )
Semnur Pharmaceuticals, Inc. ( "Semnur" ) , a wholly owned subsidiary of Scilex Holding Company SCLX "Scilex" ) ) ) , and Denali Capital Acquisition Corp.
| Ticker |
Sentiment |
Impact |
|
DECA
|
Neutral
|
10 %
|
|
SCLX
|
Somewhat Bullish
|
51 %
|
